Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00014956
DRKS00014956
Completed
未知

Prospective case-control study on supportive treatment in patients with esophageal or head and neck cancer - SynErFit

niversitätsklinikum Carl Gustav Carus Dresden0 sites101 target enrollmentJuly 16, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC00C01C02C03C04C05C06C07C08C09C10C11C12C13C14C15C30C31C32Malignant neoplasm of lipMalignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthMalignant neoplasm of parotid glandMalignant neoplasm of other and unspecified major salivary glandsMalignant neoplasm of tonsilMalignant neoplasm of oropharynxMalignant neoplasm of nasopharynxMalignant neoplasm of piriform sinusMalignant neoplasm of hypopharynxMalignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynxMalignant neoplasm of oesophagusMalignant neoplasm of nasal cavity and middle earMalignant neoplasm of accessory sinusesMalignant neoplasm of larynx

Overview

Phase
未知
Intervention
Not specified
Conditions
C00
Sponsor
niversitätsklinikum Carl Gustav Carus Dresden
Enrollment
101
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 16, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Carl Gustav Carus Dresden

Eligibility Criteria

Inclusion Criteria

  • •Gender: Both, male and female,
  • •Minimum age: 18 years,
  • •Maximum age: 80 years,
  • •Squamous cell carcinoma of the head and neck area with indication for primary or adjuvant radio (chemo) therapy,
  • •Squamous cell or adenocarcinoma of the esophagus with indication for neoadjuvant or primary radio (chemo) therapy,
  • •Histologically proven malignancy,
  • •written informed consent

Exclusion Criteria

  • •Patient with an indication for palliative radiotherapy,
  • •mandatory parenteral nutrition before initiation of radio(chemo)therapy,
  • •Pre\-existing, irreversible movement restrictions that make the intervention impossible

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study of Ayurvedic medicine â??CoReachâ?? in COVID-19 positive patients.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/05/033626Questt Clinicals and Ayurceuricals Pvt Ltd106
Completed
Not Applicable
Prospective observational study on treatment strategy for pancreatic cancer focusing on the chemotherapy responsePancreatic cancer
JPRN-UMIN000042331Department of hepato-biliary-pancreatic surgery, Okayama University Graduate School of Medicine76
Completed
Not Applicable
Prospective observational study of the treatment and prognosis in patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.Adult T-cell leukemia-lymphoma
JPRN-UMIN000009251JSCT30
Recruiting
Not Applicable
Prospective observational study of the treatment and prognosis in patients with previously untreated indolent B cell lymphomaIndolent B-cell Non-Hodgkin&#39s lymphoma
JPRN-UMIN000010175Fukuoka Lymphoma Study Group200
Completed
Phase 2
Evaluation of the effect of therapies to support facial disorders on physical, psychological, social and sleep-related aspects
RBR-7xx7g7niversidade Federal do Rio Grande do Norte